Galenum, s.r.o.

Bratislava 821 07

0 studies enrolling now · 2 studies all time

What they study most

Atrial Fibrillation, Dyslipidemia, Prevention of Stroke or Systemic Embolism, Type2 Diabetes

Studies at this site

• Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) — Stopped early
• A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke — Stopped early